Home > Products > intermedia > (3R,4S,5R,6R)-3,4,5-Tris(TriMethylsilyloxy)-6-
(3R,4S,5R,6R)-3,4,5-Tris(TriMethylsilyloxy)-6-
  • (3R,4S,5R,6R)-3,4,5-Tris(TriMethylsilyloxy)-6-(3R,4S,5R,6R)-3,4,5-Tris(TriMethylsilyloxy)-6-

(3R,4S,5R,6R)-3,4,5-Tris(TriMethylsilyloxy)-6-

Product Name:(3R,4S,5R,6R)-3,4,5-Tris(TriMethylsilyloxy)-6-(TriMethylsilyloxy)Methyl)Tetrahydro-2H-Pyran-2-OneCAS NO:32384-65-9
Formulae hypotheticae: C18H42O6Si4
Formula Pondus:466.87
Usu: Dapagliflozin Intermediates​

Mitte Inquisitionem

depictio producti

(3R,4S,5R,6R)-3,4,5-Tris(TriMethylsilyloxy)-6-

CAS NO:32384-65-9 

Usu: Dapagliflozin intermedia


Nomen chemicum 2,3,4,6-Tetrakis-O.
Synonyma (3R,4S,5R,6R)-3,4,5-Tri[(trimethylsilyl)oxy]-6-[[(Trimethylsilyl)oxy]methyl] tetrahydro-2H-pyran-2-one;
CAS Number 32384-65-9
Formulae hypotheticae C₠₈Hâ"" â‚‚O₆Siâ""
Aspectus Hyalina ad luteum oleum
Liquescens punctum N/A
M. Pondus 466.86
Repono leo
Solubilitas Chloroform (parce), Ethyl Acetate (Pariter), Methanol (Pariter)
Categoria Signa; Enzyme Activators et Inhibitores; Pharmaceutical/API Drug Impurities/Metabolites;
Applications 2,3,4,6-Tetrakis-O-trimethysilyl-D-gluconolacton est agens antidiabeticum et medium Dapagliflozin (D185370). 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone gerens agit in synthesi trans- cyclohexani gerentis C-glucosi ut sodium glucosi co-portatoris 2 inhibitores.
TRACTATIO et repono
Cautiones pro tutum pertractatio
Pellem et oculos fuge contactum. Fuge formationem pulveris et aerosols. Exhaustae evacuationi aptae praebent in locis ubi pulvis formatur.
Conditionibus ad repono tutum
Continentiam arcte clausam in loco sicco et bene ventilato. Serva in sicco loco.
Repono conditionibus: leo

Hot Tags: (3R,4S,5R,6R)-3,4,5-Tris(TriMethylsilyloxy)-6-(TriMethylsilyloxy)Methyl)Tetrahydro-2H-pyran-2-Ona, China, Suppliers, Manufacturers, Factory

Product Tag

Related Categoria

Mitte Inquisitionem

Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept